Small Molecule Allosteric Inhibitor of HIPK2 as a Novel Therapy against Kidney Fibrosis
Kyung Lee, Robert Drakas, John Cijiang He
Abstract
1Icahn School of Medicine at Mount Sinai, New York, New York 2Rila Therapeutics Inc, South San Francisco, California 3ShangPharma Innovations Inc, South San Francisco, California Correspondence: Dr. John C. He or Dr. Kyung Lee, email: [email protected] or [email protected]
Topics & Concepts
Allosteric regulationFibrosisSmall moleculeKidneyMedicinePharmacologyChemistryCancer researchInternal medicineBiochemistryReceptorinterferon and immune responsesCytokine Signaling Pathways and InteractionsCancer-related gene regulation